These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16369667)

  • 41. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.
    Nagai K; Davies TA; Ednie LM; Bryskier A; Palavecino E; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3242-5. PubMed ID: 11600391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Macrolide and ketolide resistance with Streptococcus pneumoniae.
    Doern GV
    Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium.
    Fernandez-Roblas R; Adames H; Martín-de-Hijas NZ; Almeida DG; Gadea I; Esteban J
    Int J Antimicrob Agents; 2009 May; 33(5):453-5. PubMed ID: 19153032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model.
    Tessier PR; Mattoes HM; Dandekar PK; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2005 Jan; 49(1):188-94. PubMed ID: 15616295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Activity of new quinolones against clinical isolates of Corynebacterium species].
    Yagüe Guirao G; Martínez-Toldos MC; Mora Peris B; López Domínguez R; Romero Otero M; Muñoz Bellido JL; Segovia Hernández M
    Rev Esp Quimioter; 2000 Sep; 13(3):267-70. PubMed ID: 11086275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology.
    Kays MB; Lisek CR; Denys GA
    Int J Antimicrob Agents; 2007 Mar; 29(3):289-94. PubMed ID: 17240118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An examination of the differential sensitivity to ketolide antibiotics in ermB strains of Streptococcus pyogenes and Streptococcus pneumoniae.
    Champney WS; Mentens N; Zurawick K
    Curr Microbiol; 2004 Oct; 49(4):239-47. PubMed ID: 15386111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macrolide-lincosamide-streptogramin B resistance phenotypes in clinical staphylococcal isolates.
    Cetin ES; Gunes H; Kaya S; Aridogan BC; Demirci M
    Int J Antimicrob Agents; 2008 Apr; 31(4):364-8. PubMed ID: 18206352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
    Morosini MI; Cantón R; Loza E; del Campo R; Almaraz F; Baquero F
    J Antimicrob Chemother; 2003 Jul; 52(1):50-5. PubMed ID: 12805254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ketolide resistance in Streptococcus pyogenes correlates with the degree of rRNA dimethylation by Erm.
    Douthwaite S; Jalava J; Jakobsen L
    Mol Microbiol; 2005 Oct; 58(2):613-22. PubMed ID: 16194243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [In vitro susceptibility of respiratory isolates of Streptococcus pneumoniae and Streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of e-BASKETT-II surveillance study].
    Gür D; Mülazimoğlu L; Unal S;
    Mikrobiyol Bul; 2007 Jan; 41(1):1-9. PubMed ID: 17427547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro activity of telithromycin against mefA and ermB erythromycin-resistant viridans streptococci isolated from bacteremia of oral origin in Spain.
    Tomás I; Alvarez M; López-Meléndez C; Limeres J; Tomás M; Diz P
    Oral Microbiol Immunol; 2005 Feb; 20(1):35-8. PubMed ID: 15612943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antibiotic sensitivity of Corynebacterium amycolatum].
    Zalas P; Mikucka A; Gospodarek E
    Med Dosw Mikrobiol; 2004; 56(4):327-34. PubMed ID: 15959988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrolide resistance genotypes and phenotypes among erythromycin-resistant clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci, Italy.
    Gherardi G; De Florio L; Lorino G; Fico L; Dicuonzo G
    FEMS Immunol Med Microbiol; 2009 Jan; 55(1):62-7. PubMed ID: 19076222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Time-kill kinetics of Streptococcus pneumoniae with reduced susceptibility to telithromycin.
    Al-Lahham A; Reinert RR
    Chemotherapy; 2007; 53(3):190-3. PubMed ID: 17347565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between mutations in the gyrA gene and quinolone resistance in clinical isolates of Corynebacterium striatum and Corynebacterium amycolatum.
    Sierra JM; Martinez-Martinez L; Vázquez F; Giralt E; Vila J
    Antimicrob Agents Chemother; 2005 May; 49(5):1714-9. PubMed ID: 15855486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macrolide resistance phenotypes of commensal viridans group streptococci and Gemella spp. and PCR detection of resistance genes.
    Cerdá Zolezzi P; Rubio Calvo MC; Millán L; Goñi P; Canales M; Capilla S; Durán E; Gómez-Lus R
    Int J Antimicrob Agents; 2004 Jun; 23(6):582-9. PubMed ID: 15194129
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
    Walsh F; Willcock J; Amyes S
    J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3.
    Jenkins SG; Farrell DJ; Patel M; Lavin BS
    J Infect; 2005 Dec; 51(5):355-63. PubMed ID: 15950288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solithromycin Can Specifically Induce Macrolide-Lincosamide-Streptogramin B Resistance.
    Min YH
    Microb Drug Resist; 2020 Sep; 26(9):1046-1049. PubMed ID: 32216609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.